Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Arcadia Biosciences (RKDA) Return on Equity (2016 - 2025)

Arcadia Biosciences' Return on Equity history spans 11 years, with the latest figure at 0.01% for Q3 2025.

  • For Q3 2025, Return on Equity rose 44.0% year-over-year to 0.01%; the TTM value through Sep 2025 reached 0.01%, up 44.0%, while the annual FY2024 figure was 0.29%, 18.0% up from the prior year.
  • Return on Equity reached 0.01% in Q3 2025 per RKDA's latest filing, up from 0.07% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.1% in Q3 2021 to a low of 0.73% in Q1 2022.
  • Average Return on Equity over 5 years is 0.33%, with a median of 0.32% recorded in 2023.
  • Peak YoY movement for Return on Equity: skyrocketed 230bps in 2021, then crashed -82bps in 2022.
  • A 5-year view of Return on Equity shows it stood at 0.55% in 2021, then rose by 19bps to 0.44% in 2022, then grew by 27bps to 0.32% in 2023, then decreased by -3bps to 0.33% in 2024, then skyrocketed by 98bps to 0.01% in 2025.
  • Per Business Quant, the three most recent readings for RKDA's Return on Equity are 0.01% (Q3 2025), 0.07% (Q2 2025), and 0.16% (Q1 2025).